tradingkey.logo

Enovis falls after reiterating Q1 revenue forecast, new CEO appointment

ReutersApr 2, 2025 4:55 PM

Medical device maker Enovis Corp ENOV.N down 4% at $35.76

ENOV reiterates Q1 revenue forecast to be in the range of $555 million to $563 million vs analysts' estimate of $559.6 million, according to data compiled by LSEG

Brokerage Evercore ISI analyst Vijay Kumar says shares are down partly because co reiterated Q1 forecast but did not mention forecast for the year

Separately, ENOV appoints Damien McDonald as chief executive officer effective May 12, 2025

CEO Matt Trerotola previously said in February his intention to retire

Co says Trerotola will not stand for re-election

Stock has fallen 18.6% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI